出版：MarketsandMarkets（マーケッツアンドマーケッツ） 出版年月：2023年6月
ヘルスケアデータ収益化市場 : タイプ (直接、間接)、導入 (オンプレミス、クラウド)、エンドユーザー (製薬＆バイオテクノロジー企業、医療保険支払者、医療提供者、医療技術企業)、地域別 – 2028年までの世界予測
Healthcare Data Monetization Market by Type (Direct, Indirect), Deployment (On-premise, Cloud), End User (Pharmaceutical & Biotechnology Companies, Healthcare Payers, Healthcare Providers, Medical Technology Companies), Region – Global Forecast to 2028
| ページ数 | 283 |
| 図表数 | 277 |
| 種別 | 英文調査報告書 |
| 価格 |
The healthcare data monetization market is anticipated to grow from an estimated USD 0.4 billion in 2023 to USD 0.9 billion in 2028, at a CAGR of 18.5% during the forecast period. The market has a promising growth potential due to the increase in use of external data sources and exponentially increasing data volume and generation of large and complex healthcare datasets among other factors. However, data privacy security and concerns are expected to limit the growth of this market to a certain extent.
“Direct data monetization: The fastest-growing segment of the healthcare data monetization market, by type“
The direct data monetization segment is expected to witness the fastest growth in the healthcare data monetization market during the forecast. Direct data monetization in healthcare involves selling or licensing patient data to third-party organizations to generate revenue. This practice is driven by increasing demand for healthcare data, advancements in technology, regulatory changes, and financial pressures. The emergence of data marketplaces and platforms, where organizations can directly sell and exchange healthcare data is driving the growth of this market. Furthermore, blockchain technology is gaining traction for secure and transparent data transactions. The demand for highly specific and granular datasets, such as genomics and wearables data, is driving the adoption of these solutions.
“The healthcare payers segment is anticipated to be the second largest healthcare data monetization market, by end-user, during the forecast period”
Based on end user, the market is segmented into pharmaceutical & biotechnology companies, healthcare payers, healthcare providers, medical technology companies, and other end users. The healthcare payers segment accounted for the second-largest share of the healthcare data monetization market. Payers use data to better predict risk and better manage consumers’ health through behavioral insights that they may not capture from in-house data. The healthcare industry is moving from volume-based care to value-based care, because of which payers are faced with challenges to shift their business models. Payers need data analytics tools to overcome the challenges and enable better revenue recognition, new payment models, better options to patients, and fraud detection.
“Europe accounted for the second-largest share in the healthcare data monetization market during the forecast period”
Europe accounted for the second-largest share of the healthcare data monetization market during the forecast period. The major drivers of market growth are the increasing adoption of AI-based tools, favorable government initiatives, growing EMR adoption, increasing patient data volume, raising venture capital funding, rising healthcare expenditure, and growing geriatric population. Moreover, the potential for AI in advancing R&D activities has also attracted attention to this sector.
Break of primary participants was as mentioned below:
• By Company Type – Tier 1–40%, Tier 2–35%, and Tier 3–25%
• By Designation – C-level–35%, Director-level–25%, Others–40%
• By Region – North America–45%, Europe–30%, Asia Pacific–20%, Middle East & Africa–3% and Latin America–2%
Key players in the Healthcare data monetization Market
The key players operating in the healthcare data monetization market include Oracle Corporation (US), Microsoft Corporation (US), Google (US), Salesforce, Inc. (US), SAS Institute Inc. (US), SAP SE (Germany), TIBCO Software Inc. (US), Sisense Inc. (US), Snowflake Inc. (US), QlikTech International AB (US), HealthVerity, Inc. (US), Accenture (Ireland), Availity, LLC (US), Domo, Inc. (US), Komodo Health, Inc. (US), ThoughtSpot Inc. (US), Datavant (US), Verato (US), Infor, Inc. (US), Virtusa (US), Infosys (India), Particle Health, Inc. (US), Innovaccer, Inc. (US), H1 (US), and Medoble Inc. (US).
Research Coverage:
The report analyzes the healthcare data monetization market and aims at estimating the market size and future growth potential of this market based on various segments such as type, deployment, end user, and region. The report also includes a product portfolio matrix of various healthcare data monetization products & services available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.
This report provides insights into the following pointers:
• Market Penetration: Comprehensive information on product portfolios offered by the top players in the global healthcare data monetization market. The report analyzes this market by type, deployment, and end user.
• Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global healthcare data monetization market
• Market Development: Comprehensive information on the lucrative emerging markets by type, deployment, and end user
• Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global healthcare data monetization market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global healthcare data monetization market.
目次
1 INTRODUCTION 34
1.1 STUDY OBJECTIVES 34
1.2 MARKET DEFINITION 35
1.3 INCLUSIONS & EXCLUSIONS 35
1.4 MARKET SCOPE 36
1.4.1 MARKET SEGMENTATION 36
FIGURE 1 HEALTHCARE DATA MONETIZATION MARKET: MARKET SEGMENTATION 36
1.4.2 REGIONAL SCOPE 36
1.5 YEARS CONSIDERED 37
1.6 CURRENCY 37
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 37
1.7 LIMITATIONS 38
1.8 STAKEHOLDERS 38
1.9 RECESSION IMPACT 39
2 RESEARCH METHODOLOGY 40
2.1 RESEARCH DATA 40
FIGURE 2 RESEARCH DESIGN 40
FIGURE 3 RESEARCH APPROACH 41
2.1.1 SECONDARY RESEARCH 41
2.1.1.1 Key data from secondary sources 43
2.1.2 PRIMARY RESEARCH 43
2.1.2.1 Key primary sources 44
2.1.2.2 Key data from primary sources 45
2.1.2.3 Key industry insights 45
2.1.2.4 Breakdown of primary interviews 46
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 46
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 46
2.2 MARKET SIZE ESTIMATION 46
FIGURE 6 APPROACH FOR ASSESSING SUPPLY OF HEALTHCARE DATA MONETIZATION SOLUTIONS 47
FIGURE 7 REVENUES GENERATED BY COMPANIES FROM SALES OF HEALTHCARE DATA MONETIZATION SOLUTIONS 48
FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION 49
FIGURE 9 BOTTOM-UP APPROACH 50
FIGURE 10 TOP-DOWN APPROACH 51
FIGURE 11 ESTIMATION OF HEALTHCARE DATA MONETIZATION MARKET SIZE BASED
ON PARENT MARKET 52
TABLE 2 FACTOR ANALYSIS 53
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 54
FIGURE 12 DATA TRIANGULATION METHODOLOGY 54
2.4 RESEARCH ASSUMPTIONS 55
TABLE 3 ASSUMPTIONS FOR RESEARCH STUDY 55
2.5 IMPACT OF RECESSION 56
2.6 RISK ASSESSMENT 56
TABLE 4 LIMITATIONS AND ASSOCIATED RISKS 56
2.7 RESEARCH LIMITATIONS 57
3 EXECUTIVE SUMMARY 58
FIGURE 13 HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION) 58
FIGURE 14 HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT, 2023 VS. 2028 (USD MILLION) 59
FIGURE 15 HEALTHCARE DATA MONETIZATION MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 59
FIGURE 16 HEALTHCARE DATA MONETIZATION MARKET: REGIONAL SNAPSHOT 60
4 PREMIUM INSIGHTS 61
4.1 OPPORTUNITIES IN HEALTHCARE DATA MONETIZATION MARKET 61
FIGURE 17 EXPONENTIALLY INCREASING DATA VOLUME AND GENERATION OF LARGE AND COMPLEX HEALTHCARE DATASETS TO DRIVE MARKET 61
4.2 HEALTHCARE DATA MONETIZATION MARKET, BY REGION 62
FIGURE 18 NORTH AMERICA TO DOMINATE HEALTHCARE DATA MONETIZATION MARKET DURING FORECAST PERIOD 62
4.3 HEALTHCARE DATA MONETIZATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 62
FIGURE 19 JAPAN TO REGISTER HIGHEST REVENUE GROWTH FROM 2023 TO 2028 62
4.4 NORTH AMERICAN HEALTHCARE DATA MONETIZATION MARKET, BY END USER AND COUNTRY, 2022 63
FIGURE 20 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND US DOMINATED MARKET IN NORTH AMERICA IN 2022 63
4.5 HEALTHCARE DATA MONETIZATION MARKET, BY TYPE 63
FIGURE 21 DIRECT DATA MONETIZATION SEGMENT TO HOLD LARGER MARKET SHARE IN 2028 63
4.6 HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT 64
FIGURE 22 ON-PREMISE DEPLOYMENT SEGMENT TO DOMINATE MARKET IN 2028 64
4.7 HEALTHCARE DATA MONETIZATION MARKET, BY END USER 64
FIGURE 23 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO ACCOUNT FOR LARGEST MARKET SHARE IN 2028 64
5 MARKET OVERVIEW 65
5.1 INTRODUCTION 65
5.2 MARKET DYNAMICS 65
FIGURE 24 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES: HEALTHCARE DATA MONETIZATION MARKET 65
5.2.1 DRIVERS 66
5.2.1.1 Growing use of external data sources 66
5.2.1.2 Increasing adoption of electronic health records (EHRs) 66
FIGURE 25 US: ADOPTION OF ELECTRONIC HEALTH RECORDS, BY HOSPITAL SERVICE TYPE (2021) 67
5.2.1.3 Growing volume of large and complex healthcare datasets 67
5.2.1.4 Rising need to curtail escalating healthcare costs 68
FIGURE 26 US HEALTHCARE SPENDING, 2012–2030 (USD BILLION) 68
5.2.2 RESTRAINTS 69
5.2.2.1 Lack of data standardization and interoperability 69
5.2.2.2 Regulatory constraints 70
5.2.3 OPPORTUNITIES 71
5.2.3.1 Rising demand for real-world evidence 71
5.2.3.2 Emergence of personalized medicine and genomics 73
5.2.4 CHALLENGES 74
5.2.4.1 Security concerns 74
FIGURE 27 US: NUMBER OF DATA BREACHES (2009–MAY 2023) 74
TABLE 5 LARGEST HEALTHCARE DATA BREACHES (2009–MAY 2023) 75
6 INDUSTRY TRENDS 78
6.1 INTRODUCTION 78
6.2 TYPES OF HEALTHCARE DATA MONETIZATION SOLUTIONS 78
FIGURE 28 DIRECT VS. INDIRECT DATA MONETIZATION 79
6.2.1 DIRECT DATA MONETIZATION 79
6.2.2 INDIRECT DATA MONETIZATION 79
6.3 TECHNOLOGY ANALYSIS 80
6.3.1 DATA AS A SERVICE 80
6.3.2 INSIGHT AS A SERVICE 80
6.3.3 ANALYTICS-ENABLED PLATFORM AS A SERVICE 80
6.3.4 EMBEDDED ANALYTICS 80
6.4 TARIFF AND REGULATORY LANDSCAPE 81
6.4.1 REGULATIONS 81
6.4.1.1 North America 81
6.4.1.2 Europe 82
6.4.1.3 Asia Pacific 82
6.4.1.4 Middle East & South Africa 83
6.4.1.5 Latin America 83
6.5 SUPPLY CHAIN ANALYSIS 83
FIGURE 29 HEALTHCARE DATA MONETIZATION MARKET: SUPPLY CHAIN 83
6.6 MARKET ECOSYSTEM 85
FIGURE 30 HEALTHCARE DATA MONETIZATION MARKET: MARKET ECOSYSTEM 85
6.7 PATENT ANALYSIS 86
6.7.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE DATA MONETIZATION MARKET 86
FIGURE 31 PATENT PUBLICATION TRENDS, JANUARY 2012–APRIL 2023 86
6.7.2 JURISDICTION AND TOP APPLICANT ANALYSIS 86
FIGURE 32 TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR HEALTHCARE DATA MONETIZATION SOLUTIONS, JANUARY 2012–APRIL 2023 87
FIGURE 33 TOP APPLICANT COUNTRIES/JURISDICTIONS FOR HEALTHCARE DATA MONETIZATION PATENTS, JANUARY 2012–APRIL 2023 88
TABLE 6 HEALTHCARE DATA MONETIZATION MARKET: LIST OF PATENTS/PATENT APPLICATIONS, 2020–2023 88
6.8 CASE STUDY ANALYSIS 91
6.8.1 CASE STUDY 1: TO FIND OUT INEFFICIENCIES IN HEALTHCARE CHAIN ON PER PATIENT BASIS 91
6.8.2 CASE STUDY 2: LEADING HEALTHCARE REVENUE MANAGEMENT COMPANY CUTS DEVELOPER COSTS BY 50% 92
6.8.3 CASE STUDY 3: SAKURA FINETEK EUROPE FUTURE-PROOFS ITS BUSINESS WITH ORACLE CLOUD APPLICATIONS 93
6.8.4 CASE STUDY 4: AMERISOURCEBERGEN GAINS FINANCE EFFICIENCIES WITH ORACLE CLOUD EPM 94
6.8.5 CASE STUDY 5: SKYGEN CUTS FINANCIAL CLOSE TO ONLY 10 DAYS USING ORACLE CLOUD ERP AND EPM 95
6.8.6 CASE STUDY 6: HEALTH FIRST USES AZURE SYNAPSE ANALYTICS TO CREATE A DATA MANAGEMENT SOLUTION, IMPROVING REFRESH SPEEDS BY 75% 96
6.8.7 CASE STUDY 7: COMMERCIAL UNDERWRITING 97
6.8.8 CASE STUDY 8: PRAGMATIC CLINICAL TRIALS 97
6.8.9 CASE STUDY 9: VALIDATING AUDIENCE QUALITY 98
6.8.10 CASE STUDY 10: SYNTHETIC CONTROL ARM 98
6.9 PORTER’S FIVE FORCES ANALYSIS 99
FIGURE 34 HEALTHCARE DATA MONETIZATION MARKET: PORTER’S FIVE FORCES ANALYSIS 99
TABLE 7 HEALTHCARE DATA MONETIZATION MARKET: PORTER’S FIVE FORCES ANALYSIS 99
6.9.1 THREAT OF NEW ENTRANTS 100
6.9.2 THREAT OF SUBSTITUTES 100
6.9.3 BARGAINING POWER OF SUPPLIERS 100
6.9.4 BARGAINING POWER OF BUYERS 100
6.9.5 INTENSITY OF COMPETITIVE RIVALRY 101
6.10 KEY STAKEHOLDERS AND BUYING CRITERIA 101
6.10.1 KEY STAKEHOLDERS IN BUYING PROCESS 101
FIGURE 35 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS 101
TABLE 8 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS (%) 101
6.10.2 BUYING CRITERIA 102
FIGURE 36 KEY BUYING CRITERIA, BY END USER 102
TABLE 9 KEY BUYING CRITERIA, BY END USER (%) 102
6.11 KEY CONFERENCES & EVENTS, 2023–2024 103
TABLE 10 HEALTHCARE DATA MONETIZATION MARKET: DETAILED LIST OF CONFERENCES AND EVENTS 103
6.12 AVERAGE SELLING PRICE: DATA MONETIZATION MARKET 104
TABLE 11 COMMONLY ADOPTED PRICING STRATEGIES IN HEALTHCARE DATA MONETIZATION MARKET 104
TABLE 12 MICROSOFT CORPORATION: PRICING OF AZURE HEALTH DATA SERVICES 105
TABLE 13 MICROSOFT CORPORATION: PRICING OF AZURE API FOR FHIR 105
TABLE 14 MICROSOFT CORPORATION: PRICING OF AZURE DATA SHARE 106
TABLE 15 MICROSOFT CORPORATION: PRICING OF MEDIA SERVICES 106
TABLE 16 SALESFORCE, INC.: PRICING OF HEALTH CLOUD 106
TABLE 17 SALESFORCE, INC.: PRICING OF DATA CLOUD FOR HEALTH 107
TABLE 18 SALESFORCE, INC.: PRICING OF ADDITIONAL SOLUTIONS 107
FIGURE 37 PRICING ANALYSIS: DATA MONETIZATION MARKET 108
6.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 109
6.13.1 REVENUE SHIFTS AND NEW REVENUE POCKETS FOR HEALTHCARE DATA MONETIZATION SOLUTION PROVIDERS 109
FIGURE 38 REVENUE SHIFT FOR HEALTHCARE DATA MONETIZATION SOLUTION PROVIDERS 109
7 HEALTHCARE DATA MONETIZATION MARKET, BY TYPE 110
7.1 INTRODUCTION 111
FIGURE 39 DIRECT DATA MONETIZATION SEGMENT HELD LARGEST MARKET SHARE IN 2022 111
TABLE 19 HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 111
7.2 DIRECT DATA MONETIZATION 112
FIGURE 40 DIRECT DATA MONETIZATION SOFTWARE SEGMENT DOMINATED MARKET IN 2022 113
TABLE 20 DIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 113
TABLE 21 DIRECT HEALTHCARE DATA MONETIZATION MARKET, BY REGION, 2021–2028 (USD MILLION) 114
TABLE 22 NORTH AMERICA: DIRECT HEALTHCARE DATA MONETIZATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 114
TABLE 23 EUROPE: DIRECT HEALTHCARE DATA MONETIZATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 114
TABLE 24 ASIA PACIFIC: DIRECT HEALTHCARE DATA MONETIZATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 115
7.2.1 SOFTWARE 115
7.2.1.1 Rising adoption of artificial intelligence, machine learning, and blockchain to drive growth 115
TABLE 25 DIRECT HEALTHCARE DATA MONETIZATION SOFTWARE MARKET, BY REGION, 2021–2028 (USD MILLION) 116
TABLE 26 NORTH AMERICA: DIRECT HEALTHCARE DATA MONETIZATION SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 116
TABLE 27 EUROPE: DIRECT HEALTHCARE DATA MONETIZATION SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 116
TABLE 28 ASIA PACIFIC: DIRECT HEALTHCARE DATA MONETIZATION SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 117
7.2.2 SERVICES 117
7.2.2.1 Cloud-based infrastructure, scalability, and cost-effectiveness to improve adoption of direct data monetization services 117
TABLE 29 DIRECT HEALTHCARE DATA MONETIZATION SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 118
TABLE 30 NORTH AMERICA: DIRECT HEALTHCARE DATA MONETIZATION SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 118
TABLE 31 EUROPE: DIRECT HEALTHCARE DATA MONETIZATION SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 118
TABLE 32 ASIA PACIFIC: DIRECT HEALTHCARE DATA MONETIZATION SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 119
7.3 INDIRECT DATA MONETIZATION 119
FIGURE 41 INDIRECT DATA MONETIZATION SOFTWARE SEGMENT DOMINATED MARKET IN 2022 120
TABLE 33 INDIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 120
TABLE 34 INDIRECT HEALTHCARE DATA MONETIZATION MARKET, BY REGION, 2021–2028 (USD MILLION) 120
TABLE 35 NORTH AMERICA: INDIRECT HEALTHCARE DATA MONETIZATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 121
TABLE 36 EUROPE: INDIRECT HEALTHCARE DATA MONETIZATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 121
TABLE 37 ASIA PACIFIC: INDIRECT HEALTHCARE DATA MONETIZATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 121
7.3.1 SOFTWARE 122
7.3.1.1 Growing focus on data analytics and insights to favor market growth 122
TABLE 38 INDIRECT HEALTHCARE DATA MONETIZATION SOFTWARE MARKET, BY REGION, 2021–2028 (USD MILLION) 123
TABLE 39 NORTH AMERICA: INDIRECT HEALTHCARE DATA MONETIZATION SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 123
TABLE 40 EUROPE: INDIRECT HEALTHCARE DATA MONETIZATION SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 123
TABLE 41 ASIA PACIFIC: INDIRECT HEALTHCARE DATA MONETIZATION SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 124
7.3.2 SERVICES 124
7.3.2.1 Advantages such as interoperability and data integration to boost adoption of indirect data monetization services 124
TABLE 42 INDIRECT HEALTHCARE DATA MONETIZATION SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 125
TABLE 43 NORTH AMERICA: INDIRECT HEALTHCARE DATA MONETIZATION SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 125
TABLE 44 EUROPE: INDIRECT HEALTHCARE DATA MONETIZATION SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 126
TABLE 45 ASIA PACIFIC: INDIRECT HEALTHCARE DATA MONETIZATION SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 126
8 HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT TYPE 127
8.1 INTRODUCTION 128
FIGURE 42 ON-PREMISE DATA MONETIZATION SOLUTIONS ACCOUNTED FOR LARGEST MARKET SHARE IN 2022 128
TABLE 46 HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT TYPE, 2021–2028 (USD MILLION) 128
8.2 ON-PREMISE 129
8.2.1 SECURITY CONCERNS AND GREATER CONTROL OVER SYSTEM CONFIGURATION TO DRIVE ADOPTION OF ON-PREMISE SOLUTIONS 129
TABLE 47 ON-PREMISE HEALTHCARE DATA MONETIZATION SOLUTIONS MARKET, BY REGION, 2021–2028 (USD MILLION) 129
TABLE 48 NORTH AMERICA: ON-PREMISE HEALTHCARE DATA MONETIZATION SOLUTIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 130
TABLE 49 EUROPE: ON-PREMISE HEALTHCARE DATA MONETIZATION SOLUTIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 130
TABLE 50 ASIA PACIFIC: ON-PREMISE HEALTHCARE DATA MONETIZATION SOLUTIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 130
8.3 CLOUD 131
8.3.1 GROWING NEED TO OPTIMIZE DEPLOYMENT COSTS TO FUEL GROWTH 131
TABLE 51 CLOUD-BASED HEALTHCARE DATA MONETIZATION SOLUTIONS MARKET, BY REGION, 2021–2028 (USD MILLION) 131
TABLE 52 NORTH AMERICA: CLOUD-BASED HEALTHCARE DATA MONETIZATION SOLUTIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 132
TABLE 53 EUROPE: CLOUD-BASED HEALTHCARE DATA MONETIZATION SOLUTIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 132
TABLE 54 ASIA PACIFIC: CLOUD-BASED HEALTHCARE DATA MONETIZATION SOLUTIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 132
9 HEALTHCARE DATA MONETIZATION MARKET, BY END USER 133
9.1 INTRODUCTION 134
FIGURE 43 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ACCOUNTED FOR LARGEST MARKET SHARE IN 2022 134
TABLE 55 HEALTHCARE DATA MONETIZATION MARKET, BY END USER, 2021–2028 (USD MILLION) 134
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 135
9.2.1 INTEGRATION OF REAL-WORLD DATA (RWD) AND REAL-WORLD EVIDENCE (RWE) TO BOOST MARKET GROWTH 135
TABLE 56 HEALTHCARE DATA MONETIZATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION) 135
TABLE 57 NORTH AMERICA: HEALTHCARE DATA MONETIZATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 136
TABLE 58 EUROPE: HEALTHCARE DATA MONETIZATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 136
TABLE 59 ASIA PACIFIC: HEALTHCARE DATA MONETIZATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 136
9.3 HEALTHCARE PAYERS 137
9.3.1 GROWING ADOPTION OF ADVANCED ANALYTICS TO SHAPE HEALTHCARE DATA MONETIZATION ECOSYSTEM FOR PAYERS 137
TABLE 60 HEALTHCARE DATA MONETIZATION MARKET FOR HEALTHCARE PAYERS, BY REGION, 2021–2028 (USD MILLION) 137
TABLE 61 NORTH AMERICA: HEALTHCARE DATA MONETIZATION MARKET FOR HEALTHCARE PAYERS, BY COUNTRY, 2021–2028 (USD MILLION) 137
TABLE 62 EUROPE: HEALTHCARE DATA MONETIZATION MARKET FOR HEALTHCARE PAYERS, BY COUNTRY, 2021–2028 (USD MILLION) 138
TABLE 63 ASIA PACIFIC: HEALTHCARE DATA MONETIZATION MARKET FOR HEALTHCARE PAYERS, BY COUNTRY, 2021–2028 (USD MILLION) 138
9.4 HEALTHCARE PROVIDERS 138
9.4.1 NEED TO OPTIMIZE CLINICAL WORKFLOWS AND IDENTIFY HIGH-RISK POPULATIONS TO BOOST MARKET 138
TABLE 64 HEALTHCARE DATA MONETIZATION MARKET FOR HEALTHCARE PROVIDERS, BY REGION, 2021–2028 (USD MILLION) 139
TABLE 65 NORTH AMERICA: HEALTHCARE DATA MONETIZATION MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION) 139
TABLE 66 EUROPE: HEALTHCARE DATA MONETIZATION MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION) 139
TABLE 67 ASIA PACIFIC: HEALTHCARE DATA MONETIZATION MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION) 140
9.5 MEDICAL TECHNOLOGY COMPANIES 140
9.5.1 INCREASING PENETRATION OF CONNECTED MEDICAL DEVICES AND WEARABLES TO PROPEL MARKET GROWTH 140
TABLE 68 HEALTHCARE DATA MONETIZATION MARKET FOR MEDICAL TECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION) 140
TABLE 69 NORTH AMERICA: HEALTHCARE DATA MONETIZATION MARKET FOR MEDICAL TECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 141
TABLE 70 EUROPE: HEALTHCARE DATA MONETIZATION MARKET FOR MEDICAL TECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 141
TABLE 71 ASIA PACIFIC: HEALTHCARE DATA MONETIZATION MARKET FOR MEDICAL TECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 141
9.6 OTHER END USERS 142
TABLE 72 HEALTHCARE DATA MONETIZATION MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION) 142
TABLE 73 NORTH AMERICA: HEALTHCARE DATA MONETIZATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 142
TABLE 74 EUROPE: HEALTHCARE DATA MONETIZATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 142
TABLE 75 ASIA PACIFIC: HEALTHCARE DATA MONETIZATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 143
10 HEALTHCARE DATA MONETIZATION MARKET, BY REGION 144
10.1 INTRODUCTION 145
FIGURE 44 JAPAN TO EMERGE AS NEW HOTSPOT DURING FORECAST PERIOD 145
FIGURE 45 NORTH AMERICA HELD LARGEST SHARE OF HEALTHCARE DATA MONETIZATION MARKET IN 2022 145
TABLE 76 HEALTHCARE DATA MONETIZATION MARKET, BY REGION, 2021–2028 (USD MILLION) 146
10.2 NORTH AMERICA 146
10.2.1 NORTH AMERICA: RECESSION IMPACT 147
FIGURE 46 NORTH AMERICA: HEALTHCARE DATA MONETIZATION MARKET SNAPSHOT 147
TABLE 77 NORTH AMERICA: HEALTHCARE DATA MONETIZATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 148
TABLE 78 NORTH AMERICA: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 148
TABLE 79 NORTH AMERICA: DIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 148
TABLE 80 NORTH AMERICA: INDIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 148
TABLE 81 NORTH AMERICA: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT, 2021–2028 (USD MILLION) 149
TABLE 82 NORTH AMERICA: HEALTHCARE DATA MONETIZATION MARKET, BY END USER, 2021–2028 (USD MILLION) 149
10.2.2 US 149
10.2.2.1 US to dominate North American market during forecast period 149
TABLE 83 US: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 150
TABLE 84 US: DIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 150
TABLE 85 US: INDIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 151
TABLE 86 US: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT, 2021–2028 (USD MILLION) 151
TABLE 87 US: HEALTHCARE DATA MONETIZATION MARKET, BY END USER, 2021–2028 (USD MILLION) 151
10.2.3 CANADA 152
10.2.3.1 Increasing collaborations and efforts to promote adoption of healthcare data monetization 152
TABLE 88 CANADA: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 153
TABLE 89 CANADA: DIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 153
TABLE 90 CANADA: INDIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 153
TABLE 91 CANADA: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT, 2021–2028 (USD MILLION) 153
TABLE 92 CANADA: HEALTHCARE DATA MONETIZATION MARKET, BY END USER, 2021–2028 (USD MILLION) 154
10.3 EUROPE 154
10.3.1 EUROPE: RECESSION IMPACT 155
TABLE 93 EUROPE: HEALTHCARE DATA MONETIZATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 156
TABLE 94 EUROPE: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 156
TABLE 95 EUROPE: DIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 156
TABLE 96 EUROPE: INDIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 156
TABLE 97 EUROPE: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT, 2021–2028 (USD MILLION) 157
TABLE 98 EUROPE: HEALTHCARE DATA MONETIZATION MARKET, BY END USER, 2021–2028 (USD MILLION) 157
10.3.2 UK 157
10.3.2.1 Growing penetration of wearables to fuel market growth 157
TABLE 99 UK: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 158
TABLE 100 UK: DIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 158
TABLE 101 UK: INDIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 158
TABLE 102 UK: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT, 2021–2028 (USD MILLION) 158
TABLE 103 UK: HEALTHCARE DATA MONETIZATION MARKET, BY END USER, 2021–2028 (USD MILLION) 159
10.3.3 GERMANY 159
10.3.3.1 Government initiatives to expedite development of digital healthcare ecosystem to enhance market growth 159
TABLE 104 GERMANY: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 160
TABLE 105 GERMANY: DIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 160
TABLE 106 GERMANY: INDIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 160
TABLE 107 GERMANY: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT, 2021–2028 (USD MILLION) 160
TABLE 108 GERMANY: HEALTHCARE DATA MONETIZATION MARKET, BY END USER, 2021–2028 (USD MILLION) 161
10.3.4 FRANCE 161
10.3.4.1 eHealth 2022 plan to promote use of digital technologies 161
TABLE 109 FRANCE: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 162
TABLE 110 FRANCE: DIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 162
TABLE 111 FRANCE: INDIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 162
TABLE 112 FRANCE: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT, 2021–2028 (USD MILLION) 162
TABLE 113 FRANCE: HEALTHCARE DATA MONETIZATION MARKET, BY END USER, 2021–2028 (USD MILLION) 163
10.3.5 REST OF EUROPE 163
TABLE 114 REST OF EUROPE: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 164
TABLE 115 REST OF EUROPE: DIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 164
TABLE 116 REST OF EUROPE: INDIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 164
TABLE 117 REST OF EUROPE: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT, 2021–2028 (USD MILLION) 164
TABLE 118 REST OF EUROPE: HEALTHCARE DATA MONETIZATION MARKET, BY END USER, 2021–2028 (USD MILLION) 165
10.4 ASIA PACIFIC 165
10.4.1 ASIA PACIFIC: RECESSION IMPACT 165
FIGURE 47 ASIA PACIFIC: HEALTHCARE DATA MONETIZATION MARKET SNAPSHOT 166
TABLE 119 ASIA PACIFIC: HEALTHCARE DATA MONETIZATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 166
TABLE 120 ASIA PACIFIC: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 167
TABLE 121 ASIA PACIFIC: DIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 167
TABLE 122 ASIA PACIFIC: INDIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 167
TABLE 123 ASIA PACIFIC: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT, 2021–2028 (USD MILLION) 167
TABLE 124 ASIA PACIFIC: HEALTHCARE DATA MONETIZATION MARKET, BY END USER, 2021–2028 (USD MILLION) 168
10.4.2 JAPAN 168
10.4.2.1 Growing geriatric population to increase demand for effective patient management solutions 168
TABLE 125 JAPAN: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 169
TABLE 126 JAPAN: DIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 169
TABLE 127 JAPAN: INDIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 169
TABLE 128 JAPAN: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT, 2021–2028 (USD MILLION) 169
TABLE 129 JAPAN: HEALTHCARE DATA MONETIZATION MARKET, BY END USER, 2021–2028 (USD MILLION) 170
10.4.3 CHINA 170
10.4.3.1 High prevalence of chronic diseases to drive implementation of healthcare data monetization 170
TABLE 130 CHINA: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 171
TABLE 131 CHINA: DIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 171
TABLE 132 CHINA: INDIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 171
TABLE 133 CHINA: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT, 2021–2028 (USD MILLION) 172
TABLE 134 CHINA: HEALTHCARE DATA MONETIZATION MARKET, BY END USER, 2021–2028 (USD MILLION) 172
10.4.4 REST OF ASIA PACIFIC 172
TABLE 135 REST OF ASIA PACIFIC: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 173
TABLE 136 REST OF ASIA PACIFIC: DIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 173
TABLE 137 REST OF ASIA PACIFIC: INDIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 173
TABLE 138 REST OF ASIA PACIFIC: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT, 2021–2028 (USD MILLION) 174
TABLE 139 REST OF ASIA PACIFIC: HEALTHCARE DATA MONETIZATION MARKET, BY END USER, 2021–2028 (USD MILLION) 174
10.5 LATIN AMERICA 174
10.5.1 GROWING DIGITAL HEALTH ADOPTION IN REGION TO FAVOR MARKET GROWTH 174
10.5.2 LATIN AMERICA: RECESSION IMPACT 175
TABLE 140 LATIN AMERICA: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 175
TABLE 141 LATIN AMERICA: DIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 176
TABLE 142 LATIN AMERICA: INDIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 176
TABLE 143 LATIN AMERICA: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT, 2021–2028 (USD MILLION) 176
TABLE 144 LATIN AMERICA: HEALTHCARE DATA MONETIZATION MARKET, BY END USER, 2021–2028 (USD MILLION) 177
10.6 MIDDLE EAST & AFRICA 177
10.6.1 GROWING RECOGNITION OF VALUE OF HEALTHCARE DATA IN MEA REGION TO BOOST GROWTH 177
10.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 178
TABLE 145 MIDDLE EAST & AFRICA: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 178
TABLE 146 MIDDLE EAST & AFRICA: DIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 178
TABLE 147 MIDDLE EAST & AFRICA: INDIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 179
TABLE 148 MIDDLE EAST & AFRICA: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT, 2021–2028 (USD MILLION) 179
TABLE 149 MIDDLE EAST & AFRICA: HEALTHCARE DATA MONETIZATION MARKET, BY END USER, 2021–2028 (USD MILLION) 179
11 COMPETITIVE LANDSCAPE 180
11.1 OVERVIEW 180
11.2 STRATEGIES ADOPTED BY KEY MARKET PLAYERS 180
TABLE 150 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN HEALTHCARE DATA MONETIZATION MARKET, JANUARY 2021–MAY 2023 181
11.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS, 2022 184
FIGURE 48 REVENUE SHARE ANALYSIS OF KEY MARKET PLAYERS, 2022 184
11.4 MARKET SHARE ANALYSIS 185
FIGURE 49 HEALTHCARE DATA MONETIZATION MARKET: MARKET SHARE ANALYSIS, 2022 185
11.5 COMPANY EVALUATION QUADRANT FOR KEY PLAYERS 186
11.5.1 STARS 187
11.5.2 PERVASIVE PLAYERS 187
11.5.3 EMERGING LEADERS 187
11.5.4 PARTICIPANTS 187
FIGURE 50 HEALTHCARE DATA MONETIZATION MARKET: COMPANY EVALUATION QUADRANT FOR KEY PLAYERS, 2022 188
11.6 COMPANY EVALUATION QUADRANT FOR START-UPS/SMES 189
11.6.1 PROGRESSIVE COMPANIES 189
11.6.2 DYNAMIC COMPANIES 189
11.6.3 RESPONSIVE COMPANIES 189
11.6.4 STARTING BLOCKS 189
FIGURE 51 HEALTHCARE DATA MONETIZATION MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2022 190
11.6.5 HEALTHCARE DATA MONETIZATION MARKET: COMPETITIVE BENCHMARKING 191
TABLE 151 HEALTHCARE DATA MONETIZATION MARKET: DETAILED LIST OF KEY SMES/STARTUPS 191
TABLE 152 HEALTHCARE DATA MONETIZATION MARKET: COMPETITIVE BENCHMARKING OF KEY SMES SMES/STARTUPS 191
11.7 HEALTHCARE DATA MONETIZATION MARKET: COMPANY FOOTPRINT 192
TABLE 153 BY TYPE: COMPANY FOOTPRINT 192
TABLE 154 BY END USER: COMPANY FOOTPRINT 193
TABLE 155 BY REGION: COMPANY FOOTPRINT 194
TABLE 156 COMPANY FOOTPRINT 195
11.8 COMPETITIVE SCENARIOS AND TRENDS 196
11.8.1 PRODUCT LAUNCHES & ENHANCEMENTS 196
TABLE 157 HEALTHCARE DATA MONETIZATION MARKET: PRODUCT LAUNCHES & ENHANCEMENTS, 2021–2023 196
11.8.2 DEALS 197
TABLE 158 HEALTHCARE DATA MONETIZATION MARKET: DEALS, 2021–2023 197
11.8.3 OTHER DEVELOPMENTS 198
TABLE 159 HEALTHCARE DATA MONETIZATION MARKET: OTHER DEVELOPMENTS, 2021–2023 198
12 COMPANY PROFILES 200
12.1 KEY PLAYERS 200
(Business Overview, Products & Services Offered, Recent Developments, and MnM View)*
12.1.1 ORACLE CORPORATION 200
TABLE 160 ORACLE CORPORATION: COMPANY OVERVIEW 200
FIGURE 52 ORACLE CORPORATION: COMPANY SNAPSHOT (2022) 201
TABLE 161 ORACLE CORPORATION: PRODUCT LAUNCHES 202
TABLE 162 ORACLE CORPORATION: DEALS 203
TABLE 163 ORACLE CORPORATION: OTHER DEVELOPMENTS 205
12.1.2 MICROSOFT CORPORATION 208
TABLE 164 MICROSOFT CORPORATION: COMPANY OVERVIEW 208
FIGURE 53 MICROSOFT CORPORATION: COMPANY SNAPSHOT (2022) 209
TABLE 165 MICROSOFT CORPORATION: PRODUCT ENHANCEMENTS 210
TABLE 166 MICROSOFT CORPORATION: DEALS 211
12.1.3 GOOGLE 213
TABLE 167 GOOGLE: COMPANY OVERVIEW 213
FIGURE 54 GOOGLE: COMPANY SNAPSHOT (2022) 214
TABLE 168 GOOGLE: PRODUCT LAUNCHES 215
TABLE 169 GOOGLE: DEALS 216
TABLE 170 GOOGLE: OTHER DEVELOPMENTS 217
12.1.4 SALESFORCE, INC. 219
TABLE 171 SALESFORCE, INC.: COMPANY OVERVIEW 219
FIGURE 55 SALESFORCE, INC.: COMPANY SNAPSHOT (2022) 220
TABLE 172 SALESFORCE, INC.: PRODUCT LAUNCHES & ENHANCEMENTS 222
TABLE 173 SALESFORCE, INC: DEALS 223
TABLE 174 SALESFORCE, INC.: OTHER DEVELOPMENTS 224
12.1.5 SAS INSTITUTE INC. 225
TABLE 175 SAS INSTITUTE INC.: COMPANY OVERVIEW 225
FIGURE 56 SAS INSTITUTE INC.: COMPANY SNAPSHOT (2022) 226
TABLE 176 SAS INSTITUTE INC.: PRODUCT LAUNCHES 227
TABLE 177 SAS INSTITUTE INC: DEALS 228
TABLE 178 SAS INSTITUTE INC.: OTHER DEVELOPMENTS 229
12.1.6 SAP SE 231
TABLE 179 SAP SE: COMPANY OVERVIEW 231
FIGURE 57 SAP SE: COMPANY SNAPSHOT (2022) 232
TABLE 180 SAP SE: PRODUCT LAUNCHES 234
TABLE 181 SAP SE: DEALS 234
TABLE 182 SAP SE: OTHER DEVELOPMENTS 235
12.1.7 TIBCO SOFTWARE INC. 236
TABLE 183 TIBCO SOFTWARE INC.: COMPANY OVERVIEW 236
TABLE 184 TIBCO SOFTWARE INC.: PRODUCT LAUNCHES & ENHANCEMENTS 237
TABLE 185 TIBCO SOFTWARE INC.: DEALS 238
12.1.8 SNOWFLAKE INC. 239
TABLE 186 SNOWFLAKE INC.: COMPANY OVERVIEW 239
FIGURE 58 SNOWFLAKE INC.: COMPANY SNAPSHOT (2022) 240
TABLE 187 SNOWFLAKE INC.: PRODUCT LAUNCHES & ENHANCEMENTS 241
TABLE 188 SNOWFLAKE INC.: DEALS 242
12.1.9 QLIKTECH INTERNATIONAL AB 243
TABLE 189 QLIKTECH INTERNATIONAL AB: COMPANY OVERVIEW 243
TABLE 190 QLIKTECH INTERNATIONAL AB: PRODUCT LAUNCHES & ENHANCEMENTS 244
TABLE 191 QLIKTECH INTERNATIONAL AB: DEALS 245
12.1.10 HEALTHVERITY, INC. 246
TABLE 192 HEALTHVERITY, INC.: COMPANY OVERVIEW 246
TABLE 193 HEALTHVERITY, INC.: PRODUCT LAUNCHES 247
TABLE 194 HEALTHVERITY, INC.: DEALS 248
12.1.11 SISENSE INC. 250
TABLE 195 SISENSE INC.: COMPANY OVERVIEW 250
TABLE 196 SISENSE INC.: DEALS 251
12.1.12 ACCENTURE 252
TABLE 197 ACCENTURE: COMPANY OVERVIEW 252
FIGURE 59 ACCENTURE: COMPANY SNAPSHOT (2022) 253
TABLE 198 ACCENTURE: DEALS 254
12.1.13 AVAILITY, LLC 257
TABLE 199 AVAILITY, LLC: COMPANY OVERVIEW 257
TABLE 200 AVAILITY, LLC: PRODUCT LAUNCHES 258
TABLE 201 AVAILITY, LLC: DEALS 259
12.1.14 DOMO, INC. 260
TABLE 202 DOMO, INC.: COMPANY OVERVIEW 260
FIGURE 60 DOMO, INC.: COMPANY SNAPSHOT (2022) 261
TABLE 203 DOMO, INC.: PRODUCT LAUNCHES & ENHANCEMENTS 262
12.1.15 KOMODO HEALTH, INC. 265
TABLE 204 KOMODO HEALTH, INC.: COMPANY OVERVIEW 265
TABLE 205 KOMODO HEALTH, INC.: PRODUCT LAUNCHES 266
TABLE 206 KOMODO HEALTH, INC.: DEALS 267
12.1.16 THOUGHTSPOT INC. 268
TABLE 207 THOUGHTSPOT INC.: COMPANY OVERVIEW 268
TABLE 208 THOUGHTSPOT INC.: PRODUCT LAUNCHES 268
TABLE 209 THOUGHTSPOT INC.: DEALS 269
TABLE 210 THOUGHTSPOT INC.: OTHER DEVELOPMENTS 269
12.1.17 DATAVANT 270
TABLE 211 DATAVANT: COMPANY OVERVIEW 270
TABLE 212 DATAVANT: PRODUCT LAUNCHES & ENHANCEMENTS 271
TABLE 213 DATAVANT: DEALS 272
12.1.18 VERATO 275
TABLE 214 VERATO: COMPANY OVERVIEW 275
TABLE 215 VERATO: PRODUCT LAUNCHES 276
TABLE 216 VERATO: DEALS 277
TABLE 217 VERATO: OTHER DEVELOPMENTS 277
12.2 OTHER PLAYERS 278
12.2.1 INFOR, INC. 278
12.2.2 VIRTUSA 279
12.2.3 INFOSYS 280
12.2.4 PARTICLE HEALTH, INC. 281
12.2.5 INNOVACCER, INC. 281
12.2.6 H1 282
12.2.7 MEDABLE INC. 283
* Business Overview, Products & Services Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.
13 APPENDIX 284
13.1 DISCUSSION GUIDE 284
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 289
13.3 CUSTOMIZATION OPTIONS 291
13.4 RELATED REPORTS 291
13.5 AUTHOR DETAILS 292